Case number IPR2020-01045
Teva Pharmaceuticals USA, Inc. v. Merck Sharp & Dohme Corp. > Documents
| Date Field | Doc. No. | Party | Description |
|---|---|---|---|
| Dec 8, 2020 | 25 | board | Termination Decision Document Download |
| Nov 24, 2020 | 24 | petitioner | Petitioners' Updated Exhibit List Download |
| Nov 24, 2020 | 23 | petitioner | Joint Motion to Treat Settlement Agreements (EX. 1023) as Business Confidential Information Pursuant to 35 U.S.C. s 317(b) and 37 C.F.R. s 42.74(c) and to Keep Separate Download |
| Nov 24, 2020 | 22 | petitioner | Joint Motion to Terminate IPR Pursuant to 35 U.S.C. s 317 Download |
| Sep 1, 2020 | 21 | board | Decision - Granting Institution of Inter Partes Review; Granting Motion for Joinder Download |
| Aug 20, 2020 | 20 | petitioner | Watson Laboratories, Inc.'s Updated Power of Attorney Download |
| Aug 20, 2020 | 19 | petitioner | Teva Pharmaceuticals USA, Inc.'s Updated Power of Attorney Download |
| Aug 20, 2020 | 18 | petitioner | Petitioners' Updated Mandatory Notices Download |
| Aug 14, 2020 | 2042 | patent_own | Watson Complaint Download |
| Aug 14, 2020 | 17 | patent_own | Patent Owner's Amended Exhibit List Download |
| Aug 14, 2020 | 16 | patent_own | Patent Owner's Preliminary Response Download |
| Aug 7, 2020 | 15 | board | Granting Petitioner's Motion for Pro Hac Vice Admission of Emily L. Rapalino Download |
| Jul 29, 2020 | 14 | petitioner | Petitioners' Updated Exhibit List Download |
| Jul 29, 2020 | 13 | petitioner | Petitioners' Joint Reply in Support of Motions for Joinder under 37 C.F.R. Secs. 42.22 AND 42.122(b) Download |
| Jul 29, 2020 | 1022 | petitioner | Exhibit 1022 Download |
| Jul 29, 2020 | 1021 | petitioner | Exhibit 1021 Download |
| Jul 29, 2020 | 1020 | petitioner | Exhibit 1020 Download |
| Jul 29, 2020 | 1019 | petitioner | Exhibit 1019 Download |
| Jul 27, 2020 | 12 | petitioner | Petitioners' Updated Exhibit List Download |
| Jul 27, 2020 | 11 | petitioner | Petitioners' Motion for Pro Hac Vice Admission of Emily L. Rapalino Under 37 C.F.R. s. 42.10(c) Download |
| Jul 27, 2020 | 1018 | petitioner | Declaration of Emily L. Rapalino in Support of Petitioners' Motion for Pro Hac Vice Admission Under 37 C.F.R. s. 42.10(c) Download |
| Jul 9, 2020 | 2031 | patent_own | EX2031 - Excerpt of Dr. Chyall's third declaration Download |
| Jul 9, 2020 | 10 | patent_own | Patent Owner's Exhibit List Download |
| Jul 9, 2020 | 2027 | patent_own | EX2027 - 2020.06.29 Email regarding Mylan Opposition to Schedule Change Download |
| Jul 9, 2020 | 2028 | patent_own | EX2028 - 2020.06.26 Letter to Joinder Petitioners Download |
| Jul 9, 2020 | 2029 | patent_own | EX2029 - 2020.07.01 Email from Joinder Petitioners Download |
| Jul 9, 2020 | 2030 | patent_own | Download |
| Jul 9, 2020 | 2032 | patent_own | EX2032 - U.S. Patent No. 8,309,724 Download |
| Jul 9, 2020 | 2033 | patent_own | EX2033 - WO 2013001457 Download |
| Jul 9, 2020 | 2034 | patent_own | EX2034 - Sun Pharm Indus. Ltd. Corporate Action Report Download |
| Jul 9, 2020 | 2035 | patent_own | EX2035 - 2020.07.02 Email regarding Chorghade Deposition Date Download |
| Jul 9, 2020 | 2036 | patent_own | EX2036 - 2020.07.02 Email from Mylan Reserving Rights Download |
| Jul 9, 2020 | 2037 | patent_own | EX2037 - 2020.07.02 Email from Merck to Joinder Petitioners Download |
| Jul 9, 2020 | 2038 | patent_own | EX2038 - 2020.07.07 Email from Joinder Petitioners Download |
| Jul 9, 2020 | 2039 | patent_own | EX2039 - Teva Complaint Download |
| Jul 9, 2020 | 2040 | patent_own | EX2040 - Sun Complaint Download |
| Jul 9, 2020 | 9 | patent_own | Patent Owner's Opposition to Motion for Joinder Download |
| Jul 1, 2020 | 7 | patent_own | Patent Owner's Mandatory Notices Download |
| Jul 1, 2020 | 8 | patent_own | Patent Owner's Power of Attorney Download |
| Jun 24, 2020 | 3001 | board | Ex. 3001 Download |
| Jun 22, 2020 | 6 | board | Notice of Accord Filing Date Download |
| Jun 18, 2020 | 5 | board | ORDER Conduct of the Proceeding Download |
| Jun 10, 2020 | 4 | Petitioner's Motion for Joinder Under 37 C.F.R. sec. 42.22 and 42.122(b) Download | |
| Jun 10, 2020 | 3 | Petition for Inter Partes Review of U.S. Patent No. 7,326,708 Under 35 U.S.C. sec. 311-319 and 37 C.F.R. sec. 42.1-.80, 42.100-.123 Download | |
| Jun 10, 2020 | 2 | Watson Laboratories, Inc.'s Power of Attorney Download | |
| Jun 10, 2020 | 1017 | Exhibit 1017 Download | |
| Jun 10, 2020 | 1016 | Exhibit 1016 Download | |
| Jun 10, 2020 | 1015 | Exhibit 1015 Download | |
| Jun 10, 2020 | 1014 | Exhibit 1014 Download | |
| Jun 10, 2020 | 1013 | Exhibit 1013 Download | |
| Jun 10, 2020 | 1012 | Exhibit 1012 Download | |
| Jun 10, 2020 | 1011 | Exhibit 1011 Download | |
| Jun 10, 2020 | 1010 | Exhibit 1010 Download | |
| Jun 10, 2020 | 1009 | Exhibit 1009 Download | |
| Jun 10, 2020 | 1008 | Exhibit 1008 Download | |
| Jun 10, 2020 | 1007 | Exhibit 1007 Download | |
| Jun 10, 2020 | 1006 | Exhibit 1006 Download | |
| Jun 10, 2020 | 1005 | Exhibit 1005 Download | |
| Jun 10, 2020 | 1004 | Exhibit 1004 Download | |
| Jun 10, 2020 | 1003 | Exhibit 1003 Download | |
| Jun 10, 2020 | 1002 | Exhibit 1002 Download | |
| Jun 10, 2020 | 1001 | Exhibit 1001 Download | |
| Jun 10, 2020 | 1 | Teva Pharmaceuticals USA, Inc.'s Power of Attorney Download |
